Literature DB >> 12858551

Targeted delivery of mutant Raf kinase to neovessels causes tumor regression.

J D Hood1, D A Cheresh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12858551     DOI： 10.1101/sqb.2002.67.285

Source DB:  PubMed          Journal:  Cold Spring Harb Symp Quant Biol        ISSN： 0091-7451


× No keyword cloud information.
  6 in total

Review 1.  Magnetic resonance molecular imaging with nanoparticles.

Authors:  Gregory M Lanza; Patrick M Winter; Shelton D Caruthers; Anne M Morawski; Anne H Schmieder; Katherine C Crowder; Samuel A Wickline
Journal:  J Nucl Cardiol       Date:  2004 Nov-Dec       Impact factor: 5.952

2.  CREB3L1 is a metastasis suppressor that represses expression of genes regulating metastasis, invasion, and angiogenesis.

Authors:  Paul Mellor; Leah Deibert; Brian Calvert; Keith Bonham; Svein A Carlsen; Deborah H Anderson
Journal:  Mol Cell Biol       Date:  2013-10-14       Impact factor: 4.272

3.  Inhibition of tumor endothelial ERK activation, angiogenesis, and tumor growth by sorafenib (BAY43-9006).

Authors:  Danielle A Murphy; Sosina Makonnen; Wiem Lassoued; Michael D Feldman; Christopher Carter; William M F Lee
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

4.  A small molecule disruptor of Rb/Raf-1 interaction inhibits cell proliferation, angiogenesis, and growth of human tumor xenografts in nude mice.

Authors:  Rebecca Kinkade; Piyali Dasgupta; Adam Carie; Daniele Pernazza; Melanie Carless; Smitha Pillai; Nicholas Lawrence; Said M Sebti; Srikumar Chellappan
Journal:  Cancer Res       Date:  2008-05-15       Impact factor: 12.701

5.  Selective disruption of rb-raf-1 kinase interaction inhibits pancreatic adenocarcinoma growth irrespective of gemcitabine sensitivity.

Authors:  José G Treviño; Monika Verma; Sandeep Singh; Smitha Pillai; Dongyu Zhang; Daniele Pernazza; Said M Sebti; Nicholas J Lawrence; Barbara A Centeno; Srikumar P Chellappan
Journal:  Mol Cancer Ther       Date:  2013-10-09       Impact factor: 6.261

Review 6.  Disrupting the Rb-Raf-1 interaction: a potential therapeutic target for cancer.

Authors:  Rebecca K Davis; Srikumar Chellappan
Journal:  Drug News Perspect       Date:  2008 Jul-Aug
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.